US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial
April 03, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Reports Fiscal 2023 Second Quarter Financial Results
February 08, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023
January 19, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study
January 11, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
January 04, 2023
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences
November 09, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
November 03, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
October 17, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
October 12, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
August 02, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
July 13, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results
May 04, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Host Earnings Conference Call on May 4, 2022
April 13, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences
March 22, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Announces First In-Human Experience With Company’s Propel™ Percutaneous Ventricular Assist Device
March 16, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices
February 23, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results
February 03, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Participate at SVB Leerink 2022 Global Healthcare Conference
January 27, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon
January 20, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases
January 13, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
CORRECTING and REPLACING Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
January 06, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3
January 06, 2022
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Reports Fiscal 2022 First Quarter Financial Results
November 09, 2021
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolimus Drug Coated Balloon
November 04, 2021
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Participate at the Stifel 2021 Virtual Healthcare Conference
November 02, 2021
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Webcast Fiscal 2022 First-Quarter Earnings Conference Call Tuesday, November 9
October 11, 2021
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Announces First Patient Treated with ViperCross™ Peripheral Support Catheter
September 29, 2021
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
August 30, 2021
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. Reports Fiscal 2021 Fourth Quarter and Full Year Financial Results
August 04, 2021
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
Cardiovascular Systems, Inc. to Attend Three Investor Conferences in August
July 27, 2021
From
Cardiovascular Systems, Inc.
Via
Business Wire
Tickers
CSII
